The Westaim Co. (OTCMKTS:WEDXF - Get Free Report) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 14,500 shares, a decrease of 79.8% from the December 15th total of 71,900 shares. Based on an average daily trading volume, of 93,700 shares, the short-interest ratio is currently 0.2 days.
Westaim Trading Down 0.0 %
OTCMKTS WEDXF traded down $0.01 during trading hours on Monday, reaching $20.45. The company's stock had a trading volume of 9,942 shares, compared to its average volume of 40,719. The business has a 50-day simple moving average of $5.66 and a 200 day simple moving average of $3.95. Westaim has a 52 week low of $2.55 and a 52 week high of $3.73. The stock has a market cap of $2.62 billion, a PE ratio of 70.52 and a beta of 0.45.
Westaim Company Profile
(
Get Free Report)
The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions.
Featured Stories
Before you consider Westaim, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Westaim wasn't on the list.
While Westaim currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.